93 related articles for article (PubMed ID: 22122224)
1. Managing special populations among patients with type 2 diabetes mellitus.
Marquess JG
Pharmacotherapy; 2011 Dec; 31(12 Suppl):65S-72S. PubMed ID: 22122224
[TBL] [Abstract][Full Text] [Related]
2. Overview of the guidelines and evidence for the pharmacologic management of type 2 diabetes mellitus.
Liday C
Pharmacotherapy; 2011 Dec; 31(12 Suppl):37S-43S. PubMed ID: 22122221
[TBL] [Abstract][Full Text] [Related]
3. Beyond metformin: initiating combination therapy in patients with type 2 diabetes mellitus.
Goldman-Levine JD
Pharmacotherapy; 2011 Dec; 31(12 Suppl):44S-53S. PubMed ID: 22122222
[TBL] [Abstract][Full Text] [Related]
4. Intensifying treatment of type 2 diabetes mellitus: adding insulin.
Peters KR
Pharmacotherapy; 2011 Dec; 31(12 Suppl):54S-64S. PubMed ID: 22122223
[TBL] [Abstract][Full Text] [Related]
5. [Is an evidence-based therapy of inpatients with type 2 diabetes possible from studies used for formulating therapy guidelines?].
Häuser W; Ziehl S; Poltorak P; Grandt D
Dtsch Med Wochenschr; 2005 Apr; 130(17):1069-73. PubMed ID: 15841421
[TBL] [Abstract][Full Text] [Related]
6. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
Malesker MA
Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
[TBL] [Abstract][Full Text] [Related]
7. Minimizing the risk of hypoglycemia in older adults: a focus on long-term care.
Garza H
Consult Pharm; 2009 Jun; 24 Suppl B():18-24. PubMed ID: 19555132
[TBL] [Abstract][Full Text] [Related]
8. Patient adherence to medication requirements for therapy of type 2 diabetes.
Bailey CJ; Kodack M
Int J Clin Pract; 2011 Mar; 65(3):314-22. PubMed ID: 21314869
[TBL] [Abstract][Full Text] [Related]
9. Determining effective insulin analog therapy based on the individualized needs of patients with type 2 diabetes mellitus.
Gong WC
Pharmacotherapy; 2008 Oct; 28(10):1299-308. PubMed ID: 18823224
[TBL] [Abstract][Full Text] [Related]
10. Intensified multifactorial treatment of patients with Type 2 diabetes: what can be achieved and does it pay off?
Pedersen O
J Diabetes; 2009 Jun; 1(2):83-9. PubMed ID: 20929504
[TBL] [Abstract][Full Text] [Related]
11. Implementing treatment guidelines for type 2 diabetes in primary care.
Brunton S
Postgrad Med; 2009 Mar; 121(2):125-38. PubMed ID: 19332971
[TBL] [Abstract][Full Text] [Related]
12. Managing hyperglycemia in patients with type 2 diabetes mellitus: rationale for the use of dipeptidyl peptidase-4 inhibitors in combination with other oral antidiabetic drugs.
Freeman JS
J Am Osteopath Assoc; 2010 Sep; 110(9):528-37. PubMed ID: 20876838
[TBL] [Abstract][Full Text] [Related]
13. The Journal of Human Pharmacology and Drug Therapy. Introduction.
Peters KR
Pharmacotherapy; 2011 Dec; 31(12 Suppl):35S-6S. PubMed ID: 22122220
[No Abstract] [Full Text] [Related]
14. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
Dailey G
Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
[TBL] [Abstract][Full Text] [Related]
15. The elderly and diabetes: an age trend and an epidemic converging.
Marquess JG
Consult Pharm; 2008 Apr; 23 Suppl B():5-11. PubMed ID: 18540787
[TBL] [Abstract][Full Text] [Related]
16. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
17. Controlling blood glucose levels in patients with type 2 diabetes mellitus. An evidence-based policy statement by the American Academy of Family Physicians and American Diabetes Association.
Woolf SH; Davidson MB; Greenfield S; Bell HS; Ganiats TG; Hagen MD; Palda VA; Rizza RA; Spann SJ
J Fam Pract; 2000 May; 49(5):453-60. PubMed ID: 10836779
[TBL] [Abstract][Full Text] [Related]
18. Translating clinical guidelines into clinical practice: role of the pharmacist in type 2 diabetes management.
Drab S
J Am Pharm Assoc (2003); 2009; 49(6):e152-62. PubMed ID: 19828429
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological treatment of diabetes in the elderly].
García-Lara JM; Avila-Funes JA; Aguilar-Navarro S
Rev Invest Clin; 2010; 62(4):357-65. PubMed ID: 21222315
[TBL] [Abstract][Full Text] [Related]
20. [Oral antidiabetic drugs. How to begin and combine without cardiovascular risk].
Duarte R
Rev Port Cardiol; 2013 Apr; 32 Suppl 1():15-24. PubMed ID: 23721975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
